Additionally, aberrantly glycosylated forms of MUC16 may reduce the presentation of tumor-specific peptides via HLA-A and HLA-B molecules, enabling tumor cells to escape immune system recognition and facilitating tumor immune evasion, thus promoting tumor cell survival, proliferation, growth, and metastasis within the immune microenvironment (209). This evidence concerns the gene HLA-B and neoplasm.